1. For reviews, see: (a) De Clercq, E., Walker, R. T. in Progress in Medicinal Chemistry, Ellis, G. P., West, G. B., eds, Elsevier, New York 1986, 23, chap. 5. (b) Chu, C. K., Cutter, S. J. J. Heterocycl Chem. 1986, 23, 289. (c) Remy, R. J., Secrist, J. A. Nucleosides Nucleotides 1985, 4,411. (d) Hammer, S. M. AIDS 1996,10 (Suppl. 3), S1.(e) Perigaud, C., Gosselin, G., Imbach, J.-L. Ann. Inst. Pasteur 1992, 3, 179. (f) Kulikowski, T. Pharm. World. Sci. 1994, 16, 127. (g) Harnden, M. R. Drugs of the Future 1990, 14, 3407. For review on anti-HSV agents: Alrabiah, F. A., Sacks, S. L. Drugs 1996, 52, 17. For review on anti-herpetic agents: Gough, G., Smith, P. W. Exp. Opin. Ther. Patents 1996, 6, 753.
2. (a) Elion, G. B., Furman, P. A., Fyfe, J. A. et al. J. Proc. Natl. Acad. Sci. USA 1977, 74, 5716. (b) Schaeffer, H. J., Beauchamp, L., De Miranda, P. et al. Nature, 1978, 272, 583. (c) Furman, P. A., Miranda, P., De Clair, M. H. S., Elion, G. B. Antimicrob. Agents Chemother. 1981, 20, 518.
3. De Clercq, E. in Advances in Drug Research, Testa, B., ed., Academic Press, London, 1988, pp. 1.
4. Richards, D. M., Carmine, A. A., Brogden, R. N. et al. Drugs, 1983, 26, 374.
5. Shannon, W. M. in Antiviral Agents and Viral Disease of Man, Galasso, G. J., ed., Raven Press, New York 1984, pp. 55.